Psychiatric Meds in Water Supply May Alter Fis... (ers noted. Perch that were exposed to O...)

Psychiatric Meds in Water Supply May Alter Fish Behavior

Date:2/15/2013

ers noted. "Perch that were exposed to Oxazepam lost interest in hanging out with the group, and some even stayed as far away from the group as possible," said Brodin.

The study's authors suggested the wild fish in Sweden rivers and streams may be experiencing similar changes since the concentrations of the drug found in their muscles are similar to the drug concentration in the fish examined in the study. They noted wild fish are exposed to other drugs in waterways as well, which could compound the effects on their behavior and the ecosystem.

The researchers said more studies are needed to investigate the effects of drugs on wildlife and ecosystems.

"The solution to this problem isn't to stop medicating people who are ill but to try to develop sewage treatment plants that can capture environmentally hazardous drugs," study co-author Jerker Fick, also of Umea University, said in a university news release.

More information

Find out more about psychiatric medications at the U.S. National Institute of Mental Health.

-- Mary Elizabeth Dallas

SOURCES: new releases, Science and Umea University, Feb. 14, 2013

0

GOOD

Page: 1 2
Related medicine news :

1. Scopolamine: An old drug with new psychiatric applications
2. Family practice offers genetic tests to predict effective psychiatric meds, a CAMH study
3. Frontiers publishes systematic review on the effects of yoga on major psychiatric disorders
4. Study examines link between incarceration and psychiatric disorders
5. Protecting psychiatric medical records puts patients at risk of hospitalization
6. For Psychiatric Patients, Cancer Is Often Spotted Too Late
7. Children with autism arrive at emergency room for psychiatric crisis 9 times more than peers
8. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
9. Bias found in mental health drug research presented at major psychiatric meeting
10. Psychiatric Patients Often Wait Nearly 12 Hours in ER
11. Symptomatic behaviour in childhood strongly predicts psychiatric treatment as a young adult

Post Your Comments:

Related Image:

Psychiatric Meds in Water Supply May Alter Fish Behavior

(Date:5/23/2013)... have shown that an immune regulatory molecule called IL-21 ... viral infections. , The results are published in the ... how IL-21 could be important in the development of ... PhD, the first author of the paper. The senior ... Vaccine Center and a Georgia Research Alliance Eminent Scholar. ...

(Date:5/23/2013)... Netsmart today announced it is ranked ... information technology (HIT) providers for 2013. , The HCI 100 ... Healthcare Informatics magazine. Netsmart’s ranking of #49 is up ... growth is largely due to our commitment to helping organizations ... where resources are scarce, the demand for care is unprecedented ...

(Date:5/23/2013)... patients over the past two decades have found ... of new therapies, overall mortality has decreased and ... of severe abnormal heart rhythms, has declined. ... today, with these significant improvements, one-third of patients ... diagnosed with advanced disease. Heart failure is increasingly ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 Elegance for a woman ... her flair, her taste, her intrigue can often be found in ... gateway to a woman's soul is through her eyes. It ... who she is! That is why the elegance of a woman ... . , Women today, more than any other time, utilize eyewear ...

(Date:5/23/2013)... 2013 A new report ... Medicaid program could save $2.1 billion without reducing access ... report shows that Florida and other state Medicaid programs ... and employers rely on to curb wasteful pharmacy spending. ... pharmacy at MedicaidPharmacySavings.com . , “The easiest way ...

Breaking Medicine News(10 mins):Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2 Health News:Netsmart Named to Healthcare Informatics Top 100 List 2 Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 2 Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 3 Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2 Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2

[0] Vaccine blackjack: IL-21 critical to fight against viral infections [0] Netsmart Named to Healthcare Informatics Top 100 List [0] Death rates decline for advanced heart failure patients, but outcomes are still not ideal [0] Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc.[0] PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion

... Eating Tips to Stay Balanced Through the ... ... Registered dietitian, celebrity,chef, and New York Times best-selling author Ellie Krieger, ... the benefits of,digestive health. Yo-Plus contains live and active probiotic cultures,specifically ...

... N.C., Nov. 5 Cornerstone Therapeutics,Inc. (Nasdaq ... on,developing and commercializing prescription medications for respiratory,disorders, ... of the recently,completed merger between Cornerstone BioPharma ... Collard, 42, president and chief executive,officer and ...

... 5 CardiacAssist, Inc. announced that,it reached a new high ... least one TandemHeart case during the third quarter of 2008.,In ... on,year growth in case activity with a leap of 64 ... and 497 %. Through nine months of 2008,CardiacAssist has also ...

... Corporate Highlights:, -- Net service revenues increased 84% to $58.7 ... to $48.6 million -- Net income increased 149% to $4.7 ... share on 49% more shares -- Completed acquisition of Patient ... 200 Best Small Companies List, Almost Family, Inc. (Nasdaq: ...

... to ... 9-hour flights, HOBOKEN, N.J., Nov. 5 ... pine bark,extract from the French maritime pine tree, reduces jetlag in passengers ... and a,scoring system, showed Pycnogenol(R) lowered symptoms of jetlag such as,fatigue, headaches, ...

... Nov. 5 CuraGen Corporation,(Nasdaq: CRGN ), a ... Timothy M. Shannon, President and Chief,Executive Officer, will present ... Investment Conference on Wednesday, November 12, 2008, at,3:15 p.m. ... New York Palace,Hotel in New York, NY., Access ...

Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health Cornerstone Therapeutics Announces New Board of Directors CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results Almost Family Reports Third Quarter 2008 Results Study Shows Pine Bark Reduces Jetlag CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...

(Date:5/23/2013)... , May 23, 2013 BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...

(Date:5/23/2013)... and PARIS , May ... ), a leading developer and manufacturer of precision guided ... of coronary and peripheral vascular disease, today announced preliminary ... asodilator I ndependent S tenosis E ... clinical trial session at EuroPCR 2013. These prospective results ...

Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5

[0] Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share [0] BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress [0] Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013

... Phase II Testing Certification with Edifecs CORE Testing Service ... in X12 Version 5010BELLEVUE, Wash., April 5 ... its partners CAQH and Harvard Pilgrim Health Care, examine ... II Certification testing including elements of the newly mandated ...

... SILVER SPRING, Md., April 2 Novo Nordisk today announced ... United States Food and Drug Administration (FDA) has finalized its ... analogue. The Advisory Committee voted on questions related to the ... , A majority ...

Cached Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

... an independent laboratory to ... of Federal Standard 209E. ... confort, reduces fatique and ... meets Class 100 particle ...

Medicine Products:

4V62 4V42-R 4V41-R Class 100 Chair